65 related articles for article (PubMed ID: 712062)
1. p30-Anti-p30 immune complexes: intravascular clearance and extravascular sequestration in rats bearing Moloney sarcoma.
Jennette JC; Feldman JD
J Immunol; 1978 Nov; 121(5):1696-700. PubMed ID: 712062
[TBL] [Abstract][Full Text] [Related]
2. Sequential quantitation of circulating immune complexes in syngeneic and allogeneic rats bearing Moloney sarcomas.
Jennette JC; Feldman JD
J Immunol; 1977 Jun; 118(6):2269-74. PubMed ID: 301157
[TBL] [Abstract][Full Text] [Related]
3. Consistent fluctuations in quantities of circulating immune complexes during progressive and regressive phases of tumor growth.
Jennette JC
Am J Pathol; 1980 Aug; 100(2):403-10. PubMed ID: 7406017
[TBL] [Abstract][Full Text] [Related]
4. In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma.
Fernandez-Cruz E; Halliburton B; Feldman JD
J Immunol; 1979 Oct; 123(4):1772-7. PubMed ID: 158055
[TBL] [Abstract][Full Text] [Related]
5. Immunization with p30 enhances the growth of a rat Moloney sarcoma.
Jones JM; Kennel SJ; Feldman JD
J Immunol; 1977 Jan; 118(1):371-3. PubMed ID: 830759
[No Abstract] [Full Text] [Related]
6. Effect of macrophages and antibodies on in vivo growth of Moloney sarcoma in the rat.
Miller GA; Feldman JD
J Immunol; 1977 Oct; 119(4):1445-51. PubMed ID: 302284
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated antigens of rat moloney sarcoma cells. II. Cytosol antigens.
Leung K; Feldman JD
J Immunol; 1978 Nov; 121(5):1844-8. PubMed ID: 309482
[TBL] [Abstract][Full Text] [Related]
8. Immune complexes with antiglobulin activity in sera of Moloney sarcoma-bearing rats.
Balint JR
Clin Exp Immunol; 1982 Apr; 48(1):70-8. PubMed ID: 6979450
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated antigens of rat moloney sarcoma cells. I. Cell-surface antigens.
Leung K; Jones JM; Feldman JD
J Immunol; 1978 Nov; 121(5):1836-43. PubMed ID: 81854
[TBL] [Abstract][Full Text] [Related]
10. Clearance kinetics and organ uptake of complement-solubilized immune complexes in mice.
Aguado MT; Mannik M
Immunology; 1987 Feb; 60(2):255-60. PubMed ID: 3817872
[TBL] [Abstract][Full Text] [Related]
11. Isolation of circulating immune complexes using Raji cells. Separation of antigens from immune complexes and production of antiserum.
Theofilopoulos AN; Eisenberg RA; Dixon FJ
J Clin Invest; 1978 Jun; 61(6):1570-81. PubMed ID: 659616
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting passive monoclonal antibody therapy of Moloney sarcoma in BALB/c mice.
Kennel SJ; Lankford PK; Flynn KM; Winegar R
Cancer Res; 1985 Aug; 45(8):3782-9. PubMed ID: 2410101
[TBL] [Abstract][Full Text] [Related]
13. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
McDonald TL
J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
[TBL] [Abstract][Full Text] [Related]
14. Alloantigen expression of a rat Moloney sarcoma.
Jones JM; Feldman JD
J Natl Cancer Inst; 1975 Oct; 55(4):995-9. PubMed ID: 52723
[TBL] [Abstract][Full Text] [Related]
15. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.
Schifferli JA; Ng YC; Estreicher J; Walport MJ
J Immunol; 1988 Feb; 140(3):899-904. PubMed ID: 2963069
[TBL] [Abstract][Full Text] [Related]
16. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
Kobayashi H; Yoo TM; Drumm D; Kim MK; Sun BF; Le N; Webber KO; Pastan I; Waldmann TA; Paik CH; Carrasquillo JA
Cancer Res; 1997 May; 57(10):1955-61. PubMed ID: 9157991
[TBL] [Abstract][Full Text] [Related]
17. A study of in vivo immune complex formation and clearance in man.
Davies KA; Hird V; Stewart S; Sivolapenko GB; Jose P; Epenetos AA; Walport MJ
J Immunol; 1990 Jun; 144(12):4613-20. PubMed ID: 2141040
[TBL] [Abstract][Full Text] [Related]
18. Altered levels of mononuclear leukocytes in tumor-bearing rats: decrease of helper T lymphocytes and increase of suppressor cells.
Fernandez-Cruz E; Gilman SC; Feldman JD
J Immunol; 1982 Sep; 129(3):1324-8. PubMed ID: 6213711
[TBL] [Abstract][Full Text] [Related]
19. Induction of effective immunity to Moloney murine sarcoma virus using monoclonal anti-idiotypic antibody as immunogen.
Powell TJ; Spann R; Nguyenduc M; Lamon EW
J Immunol; 1989 Feb; 142(4):1318-24. PubMed ID: 2536772
[TBL] [Abstract][Full Text] [Related]
20. Receptor sites for antigen-antibody complexes on cells derived from solid tumors: detection by means of antibody sensitized sheep erythrocytes labeled with technetium-99m.
Wood GW; Gillespie GY; Barth RF
J Immunol; 1975 Mar; 114(3):950-7. PubMed ID: 1089728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
